OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
A new mass spectrometry technique captures molecules of lower abundance in a sample, providing a more comprehensive sample ...
Nitrosamines are becoming a regular topic across many industries. They have been studied and monitored for decades in areas ...
Agilent earns its premium valuation through superior execution, resilient revenue balance, and strong margin-driven growth.
A review of some of the content highlights from LCGC International in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results